Skip to main content
EOFlow Co., Ltd. logo

EOFlow Co., Ltd. — Investor Relations & Filings

Ticker · 294090 ISIN · KR7294090006 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2026-05-27 Director's Dealing
Country KR South Korea
Listing KO 294090

About EOFlow Co., Ltd.

https://www.eoflow.com

EOFlow Co., Ltd. is a medical device company that develops and provides wearable drug delivery solutions. Its flagship product is the EOPatch, a disposable, wearable insulin pump system designed for the continuous delivery of insulin to manage blood glucose levels in individuals with diabetes. The company leverages its proprietary technology and manufacturing expertise to create reliable and accessible drug delivery platforms. EOFlow also collaborates with partners to integrate its pump technology into automated insulin delivery (AID) systems, advancing diabetes care management.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a formal “임원·주요주주 특정증권등 소유상황보고서” filed with the Securities and Futures Commission and Korea Exchange, detailing an executive’s and major shareholder’s stock and option holdings and changes. It reports personal shareholdings and acquisitions by a company director (권대우), matching the “Director’s Dealing” category for insider transactions. It is not an annual or interim report, earnings release, or mere publication notice but a regulatory insider ownership filing.
2026-05-27 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 80% confidence The document is a regulatory filing to the Korean Financial Services Commission and Korea Exchange (“금융위원회/한국거래소 귀중”) detailing the terms of a stock option grant (주식매수선택권 부여) including grant date, recipient, number of options, exercise price, legal basis, and related capital issuance conditions. It is not an annual report or earnings release, nor is it an insider personal trade (DIRS) or share repurchase. This is specifically an announcement of a contingent equity issuance (stock option grant) under corporate law. Under our taxonomy, this falls under Share Issue/Capital Change (SHA).
2026-05-22 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings Classification · 78% confidence The document is a Korean regulatory disclosure titled “주식매수선택권 부여에 관한 신고” (Notice of Granting Stock Options), filed with the Financial Supervisory Service and Korea Exchange. It details the grant of stock purchase options, the number of options, exercise conditions and references corporate bylaws. It is not an annual or quarterly report, earnings release, M&A filing, director trade, or proxy statement. It is a standalone regulatory announcement of a corporate capital-related action that does not neatly fit other specific categories, making it a fallback “Regulatory Filing.”
2026-05-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 91% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” filed to the Financial Services Commission and Korea Exchange. It details an officer’s (CFO 권대우) personal shareholding and changes (acquisitions via purchase and stock options). This is clearly a director’s insider transaction report rather than a general voting result or dividend notice.
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026, includes detailed company overview, product descriptions, financial tables, production data, R&D activities, etc. It is the full interim/quarterly financial report itself, not merely an announcement or summary. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
반기또는분기매출액미달사실발생
Regulatory Filings Classification · 90% confidence The document is a short regulatory disclosure notifying that quarterly (or half-year) revenues fell below a specified threshold (3억원). It does not contain a full interim report or earnings release, nor strategic discussion, but rather a compliance notice under listing rules. This fits the fallback category for general regulatory announcements (RNS).
2026-05-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.